Skip to Content

Publications

Badal SS, Danesh FR. Strategies to reverse endothelial dysfunction in diabetic
nephropathy. Kidney Int. 2012 Dec;82(11):1151-4. doi: 10.1038/ki.2012.306. PubMed
PMID: 23151985.

Wang W, He B, Shi W, Liang X, Ma J, Shan Z, Hu Z, Danesh FR. Deletion of
scavenger receptor A protects mice from progressive nephropathy independent of
lipid control during diet-induced hyperlipidemia. Kidney Int. 2012
May;81(10):1002-14. doi: 10.1038/ki.2011.457. Epub 2012 Feb 29. PubMed PMID:
22377830; PubMed Central PMCID: PMC3343314.

Wang W, Wang Y, Long J, Wang J, Haudek SB, Overbeek P, Chang BH, Schumacker
PT, Danesh FR. Mitochondrial fission triggered by hyperglycemia is mediated by
ROCK1 activation in podocytes and endothelial cells. Cell Metab. 2012 Feb
8;15(2):186-200. doi: 10.1016/j.cmet.2012.01.009. PubMed PMID: 22326220; PubMed
Central PMCID: PMC3278719.

Badal SS, Danesh FR. Managing microvascular complications of diabetes with
microRNAs. J Am Soc Nephrol. 2012 Feb;23(2):185-7. doi: 10.1681/ASN.2011121222.
Epub 2012 Jan 12. PubMed PMID: 22241893; PubMed Central PMCID: PMC3269171.

Bakota EL, Wang Y, Danesh FR, Hartgerink JD. Injectable multidomain peptide
nanofiber hydrogel as a delivery agent for stem cell secretome.
Biomacromolecules. 2011 May 9;12(5):1651-7. doi: 10.1021/bm200035r. Epub 2011 Apr
13. PubMed PMID: 21417437; PubMed Central PMCID: PMC3150749.

Wang Y, Bakota E, Chang BH, Entman M, Hartgerink JD, Danesh FR. Peptide
nanofibers preconditioned with stem cell secretome are renoprotective. J Am Soc
Nephrol. 2011 Apr;22(4):704-17. doi: 10.1681/ASN.2010040403. Epub 2011 Mar 17.
PubMed PMID: 21415151; PubMed Central PMCID: PMC3065226.

Long J, Wang Y, Wang W, Chang BH, Danesh FR. MicroRNA-29c is a signature
microRNA under high glucose conditions that targets Sprouty homolog 1, and its in
vivo knockdown prevents progression of diabetic nephropathy. J Biol Chem. 2011
Apr 1;286(13):11837-48. doi: 10.1074/jbc.M110.194969. Epub 2011 Feb 10. PubMed
PMID: 21310958; PubMed Central PMCID: PMC3064234.

Bakris G, Vassalotti J, Ritz E, Wanner C, Stergiou G, Molitch M, Nesto R,
Kaysen GA, Sowers JR; CKD Consensus Working Group. National Kidney Foundation
consensus conference on cardiovascular and kidney diseases and diabetes risk: an
integrated therapeutic approach to reduce events. Kidney Int. 2010
Oct;78(8):726-36. doi: 10.1038/ki.2010.292. Epub 2010 Aug 18. PubMed PMID:
20720529.

Long J, Wang Y, Wang W, Chang BH, Danesh FR. Identification of microRNA-93 as
a novel regulator of vascular endothelial growth factor in hyperglycemic
conditions. J Biol Chem. 2010 Jul 23;285(30):23457-65. doi:
10.1074/jbc.M110.136168. Epub 2010 May 25. PubMed PMID: 20501654; PubMed Central
PMCID: PMC2906336.

Wang J, Wang Y, Long J, Chang BH, Wilson MH, Overbeek P, Danesh FR.
Tamoxifen-inducible podocyte-specific iCre recombinase transgenic mouse provides
a simple approach for modulation of podocytes in vivo. Genesis. 2010
Jul;48(7):446-51. doi: 10.1002/dvg.20635. PubMed PMID: 20641128; PubMed Central
PMCID: PMC3014324.

Sun L, Xie P, Wada J, Kashihara N, Liu FY, Zhao Y, Kumar D, Chugh SS, Danesh
FR, Kanwar YS. Rap1b GTPase ameliorates glucose-induced mitochondrial
dysfunction. J Am Soc Nephrol. 2008 Dec;19(12):2293-301. doi:
10.1681/ASN.2008030336. Epub 2008 Aug 27. PubMed PMID: 18753253; PubMed Central
PMCID: PMC2588105.


© 2014 The University of Texas MD Anderson Cancer Center